CytoDyn Inc. reported earnings results for the first quarter ended August 31, 2023. For the first quarter, the company reported net loss was USD 11.57 million compared to USD 20.99 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1456 USD | +0.41% | -0.95% | -25.33% |
04-15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
03-05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-25.33% | 145M | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.73% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023